FDA UDI Not in Commercial Distribution 🇺🇸 United States

Revogene® C. difficile

DI: 00628055344124 · Model: 410300 · Meridian Bioscience Canada Inc
Product Codes
1
GMDN Terms
1
Identifiers
1
Pkg Device Count
1

Basic Information

Brand Name
Revogene® C. difficile
Primary DI
00628055344124
Version / Model
410300
Catalog Number
410300
Company Name
Meridian Bioscience Canada Inc
Labeler DUNS
204006360
Distribution Status
Not in Commercial Distribution
Device Count in Pkg
1
Record Status
Published
Publish Date
2019-10-21
Public Version
3
Public Version Date
2021-11-08
Public Version Status
Update
Public Device Record Key
14b899ec-0be2-41ec-a5f1-8407501df24b
Distribution End Date
2021-09-30

Device Description

The Revogene® C. difficile assay performed on the Revogene instrument is a qualitative in vitro diagnostic test that utilizes automated sample processing and real-time polymerase chain reaction (PCR) to detect the toxin B (tcdB) gene of toxigenic Clostridium difficile (C. difficile) in unformed (liquid or soft) stool specimens obtained from patients suspected of having C. difficile infection (CDI). The Revogene C. difficile assay is intended to aid in the diagnosis of CDI.

Device Characteristics

Single Use
Yes
Prescription Use (Rx)
Yes
Over the Counter (OTC)
No
Kit
Yes
Combination Product
No
HCT/P
No
Contains NRL
No
Not Made with NRL
No
MRI Safety
Labeling does not contain MRI Safety Information
Direct Marking Exempt
No
PM Exempt
No
Has Serial Number
No
Has Lot/Batch Number
Yes
Has Manufacturing Date
No
Has Expiration Date
Yes
Has Donation ID
No

Sterilization

Is Sterile
No
Sterilization Prior Use
No

Product Codes

Code Name
OZN C. Difficile Toxin Gene Amplification Assay

GMDN Terms

Code Name
50836 Clostridium difficile nucleic acid IVD, kit, nucleic acid technique (NAT)

Identifiers

Type ID
Primary 00628055344124

Customer Contacts

Storage Conditions

Type
Storage Environment Temperature
Temperature Range
2 – 25 Degrees Celsius